tiprankstipranks
China Regenerative Medicine International Limited (HK:8158)
HKEX:8158
Hong Kong Market
8158
China Regenerative Medicine International Limited
RESEARCH TOOLSreports

China Regenerative Medicine International Limited (8158) Stock Price & Analysis

0 Followers

8158 Stock Chart & Stats

Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.09 - HK$1.20
Previous CloseHK$0.17
Volume7.20K
Average Volume (3M)36.91K
Market Cap
HK$50.20M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)3.1
Beta-0.08
Aug 09, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding285,428,950
10 Day Avg. Volume5,631
30 Day Avg. Volume36,906
Standard Deviation0.25
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

8158 FAQ

What was China Regenerative Medicine International Limited’s price range in the past 12 months?
China Regenerative Medicine International Limited lowest stock price was HK$0.09 and its highest was HK$1.20 in the past 12 months.
    What is China Regenerative Medicine International Limited’s market cap?
    Currently, no data Available
    When is China Regenerative Medicine International Limited’s upcoming earnings report date?
    China Regenerative Medicine International Limited’s upcoming earnings report date is Aug 09, 2024 which is in 39 days.
      How were China Regenerative Medicine International Limited’s earnings last quarter?
      Currently, no data Available
      Is China Regenerative Medicine International Limited overvalued?
      According to Wall Street analysts China Regenerative Medicine International Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does China Regenerative Medicine International Limited pay dividends?
        China Regenerative Medicine International Limited does not currently pay dividends.
        What is China Regenerative Medicine International Limited’s EPS estimate?
        China Regenerative Medicine International Limited’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does China Regenerative Medicine International Limited have?
        China Regenerative Medicine International Limited has 304,252,470 shares outstanding.
          What happened to China Regenerative Medicine International Limited’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of China Regenerative Medicine International Limited?
          Currently, no hedge funds are holding shares in HK:8158
          ---

          China Regenerative Medicine International Limited Stock Smart Score

          Company Description

          China Regenerative Medicine International Limited

          China Regenerative Medicine International Ltd is a biotechnology company that researches and commercializes regenerative medicine products in China. CRMI focuses on five major business segments: Dermatology, cosmetic products and others, Cell and healthcare products and services, Ophthalmology products, Stomatology products and others, and Medical equipment. Geographically, the People's Republic of China accounts for majority revenue. The vast majority of the company's revenue is derived from its Medical equipment segment.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Shanghai Haohai Biological Technology Co., Ltd. Class H
          KOALA Financial Group
          J&T Global Express Limited
          Grand T G Gold Holdings Ltd
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis